Literature DB >> 21383687

Tear physiology in dry eye associated with chronic GVHD.

S Khanal1, A Tomlinson.   

Abstract

The purpose of this study was to compare tear physiology characteristics of chronic GVHD (cGVHD)-associated dry eye to dry eye caused by Sjogren's syndrome (SS), a extreme form of aqueous-deficient dry eye, and meibomian gland dysfunction (MGD), the major cause of evaporative dry eye. Tear turnover rate, evaporation and osmolarity along with meibomian gland dropout and lipid layer interferometric patterns were assessed in the right eyes of 12 patients with dry eye associated with cGVHD, 12 age-matched patients with SS and 12 age-sex matched subjects with MGD. In cGVHD, the decrease in tear turnover rate was similar (P=0.33), but the number of non-functioning meibomian glands was significantly higher (P<0.01) than in SS. Tear evaporation rate in cGVHD dry eye was found to be similar to that in MGD (P=0.36) and significantly higher than in SS (P<0.01). The lipid layer was most unstable in cGVHD compared with other groups. There was no variation in tear volume across all groups. Although statistical significance was not detected, the mean tear osmolarity (333.51±14.67mOsm/L) was highest in cGVHD. Major aspects of tear physiology were severely impaired in cGVHD-associated dry eye.

Entities:  

Mesh:

Year:  2011        PMID: 21383687     DOI: 10.1038/bmt.2011.36

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  10 in total

1.  Assessing the ocular surface microbiome in severe ocular surface diseases.

Authors:  Michael J Zilliox; William S Gange; Gina Kuffel; Carine R Mores; Cara Joyce; Paul de Bustros; Charles S Bouchard
Journal:  Ocul Surf       Date:  2020-07-24       Impact factor: 5.033

2.  Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease.

Authors:  Jianyu Weng; Chang He; Peilong Lai; Chenwei Luo; Rong Guo; Suijing Wu; Suxia Geng; Andy Xiangpeng; Xialin Liu; Xin Du
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

3.  Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.

Authors:  Kyung-Sun Na; Man Soo Kim
Journal:  J Ocul Pharmacol Ther       Date:  2012-06-25       Impact factor: 2.671

4.  Toll-like receptor 2-mediated NF-κB inflammatory responses in dry eye associated with cGVHD.

Authors:  Chang He; Peilong Lai; Jianyu Weng; Shaoze Lin; Kaili Wu; Xin Du; Xialin Liu
Journal:  Mol Vis       Date:  2011-10-05       Impact factor: 2.367

5.  Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation.

Authors:  Anjo Riemens; Elena Stoyanova; Aniki Rothova; Jonas Kuiper
Journal:  Mol Vis       Date:  2012-04-01       Impact factor: 2.367

Review 6.  Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations.

Authors:  Nariman Nassiri; Medi Eslani; Nekoo Panahi; Shiva Mehravaran; Alireza Ziaei; Ali R Djalilian
Journal:  J Ophthalmic Vis Res       Date:  2013-10

7.  Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome.

Authors:  Yi Wang; Qiyu Qin; Bo Liu; Yana Fu; Lin Lin; Xiaodan Huang; Xiuming Jin
Journal:  Front Med (Lausanne)       Date:  2019-12-10

Review 8.  Update on ocular graft-versus-host disease.

Authors:  Sridevi Nair; Murugesan Vanathi; Ritika Mukhija; Radhika Tandon; Sandeep Jain; Yoko Ogawa
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

Review 9.  Adult human mesenchymal stromal cells and the treatment of graft versus host disease.

Authors:  Richard P Herrmann; Marian J Sturm
Journal:  Stem Cells Cloning       Date:  2014-02-28

10.  Multiple Natural and Experimental Inflammatory Rabbit Lacrimal Gland Phenotypes.

Authors:  Austin K Mircheff; Yanru Wang; Joel E Schechter; Meng Li; Warren Tong; Mayssa Attar; Murty Chengalvala; Joe Harmuth; Jeffery J Prusakiewicz
Journal:  Ocul Surf       Date:  2016-07-15       Impact factor: 5.033

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.